학술논문

569PISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer.
Document Type
Article
Source
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Subject
*COLORECTAL cancer
*BEVACIZUMAB
*FLUOROURACIL
*ACADEMIC medical centers
Language
ISSN
0923-7534